AN2 Therapeutics, Inc. (ANTX)
4.94
-0.50
(-9.19%)
USD |
NASDAQ |
Mar 13, 16:00
4.95
+0.01
(+0.20%)
After-Hours: 20:00
AN2 Therapeutics Market Cap : 135.37M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Relmada Therapeutics, Inc. | 433.40M |
| ACADIA Pharmaceuticals, Inc. | 3.514B |
| Alnylam Pharmaceuticals, Inc. | 41.57B |
| Savara, Inc. | 1.068B |
| BioMarin Pharmaceutical, Inc. | 11.25B |
Market Cap Related Metrics
| Price to Book Value | 2.242 |
| Price | 4.94 |
| Earnings Yield | -22.86% |